Europe Drug Regulator Backs Use Of Moderna’s COVID-19 Booster Vaccine
The European Union’s drug regulator on Monday said it has concluded in its review that Moderna’s COVID-19 booster vaccine may be given to people aged 18 years and above, at least six months after the second dose. It is the second COVID-19 booster vaccine to be approved in the EU. “This follows data showing that a third dose of Spikevax given 6 to 8 months after the second dose led to a rise in antibody levels in adults whose antibody levels were waning,” the European Medicines Agency (EMA) said.
Read more on CDE News